chr19-3595692-T-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001060.6(TBXA2R):c.1028A>G(p.Gln343Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000114 in 1,584,352 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001060.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TBXA2R | NM_001060.6 | c.1028A>G | p.Gln343Arg | missense_variant | 3/3 | ENST00000375190.10 | NP_001051.1 | |
TBXA2R | XM_011528214.3 | c.1028A>G | p.Gln343Arg | missense_variant | 4/4 | XP_011526516.1 | ||
TBXA2R | NM_201636.3 | c.983+45A>G | intron_variant | NP_963998.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TBXA2R | ENST00000375190.10 | c.1028A>G | p.Gln343Arg | missense_variant | 3/3 | 1 | NM_001060.6 | ENSP00000364336.4 | ||
TBXA2R | ENST00000589966.1 | c.639A>G | p.Ala213Ala | synonymous_variant | 2/2 | 1 | ENSP00000468145.1 | |||
TBXA2R | ENST00000411851.3 | c.983+45A>G | intron_variant | 2 | ENSP00000393333.2 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152230Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000102 AC: 2AN: 196594Hom.: 0 AF XY: 0.0000188 AC XY: 2AN XY: 106474
GnomAD4 exome AF: 0.00000978 AC: 14AN: 1432122Hom.: 0 Cov.: 70 AF XY: 0.0000127 AC XY: 9AN XY: 709198
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152230Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74376
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 02, 2024 | The c.1028A>G (p.Q343R) alteration is located in exon 3 (coding exon 2) of the TBXA2R gene. This alteration results from a A to G substitution at nucleotide position 1028, causing the glutamine (Q) at amino acid position 343 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 20, 2023 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant  is likely to be tolerated. This variant has not been reported in the literature in individuals affected with TBXA2R-related conditions. This variant is present in population databases (rs775815868, gnomAD 0.01%). This sequence change replaces glutamine, which is neutral and polar, with arginine, which is basic and polar, at codon 343 of the TBXA2R protein (p.Gln343Arg). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at